CY (Cyprus) Asiandouble Eyelid

Asiandouble Eyelid Related Terms:
Asiandouble Eyelid In CY Cyprus, CY Asian Blepharoplasty, CY Blepharoplasty, CY Canthoplasty, CY Cosmetic Asian Eyelid Surgery, CY Cosmetic Surgery, CY Double Eyelid Surgery For The Asian Eye, CY Double Eyelid Surgery, CY Eyebags Surgery, CY Eyelash Transplant, CY Eyelid Ptosis Surgery, CY Eyelid Surgery Blepharoplasty, CY Eyelid Surgery, CY Eyelid Tightening, CY Eyelid Tuck, CY Face Procedures, CY Inside Lower Eyelid, CY Keratoplasty, CY Orbital Fat Grafting, CY Outside Lower Eyelid, CY Plastic Surgery, CY Skin Procedures, CY Surgeon, CY Upper Eyelid

Asiandouble Eyelid in CY (Cyprus) - What Is It?

People born with a weak or low eyelid crease or no eyelid crease seek double eyelid surgery. Since nearly half of the Asians are born with a weak upper eyelid crease and resort to corrective surgery. As such, this plastic surgery had been termed as Asian double eyelid surgery and this condition is known as Asian double eyelid. Even though facial beauty is not related to prominent eyelid creases, any cosmetic procedure to enhance the looks is a personal decision. Data reveal that many persons of Asian descent opt for double eyelid surgery to improve their appearance.

[asiandouble eyelid CY top]

Planing on having asiandouble eyelid procedure in CY?
Here is some General Information about CY:

Cyprus Travelling to and from the north

Prior to Cyprus's accession to European Union, evidence of entry to Northern Cyprus resulted in denial of entry to the Greek part of Cyprus at the very least. After the accession and according to EU legislation that considers Cyprus to have been admitted in full an entry to the Turkish part is formally an entry to whole Cyprus and must therefore not result in any disadvantage to travellers from the EU. Travellers from non-EU member states (as, for instance, Turkish citizens) must enter the island via one of the legal entry points (i.e. entry points in the Southern part of the island) in order to visit the Southern part.

The Cyprus embassy in Washington on the phone (June 2006) when asked if the border is open to U.S. citizens, didn't give a 'No', but said that they recommend entering from the "legal" points in the Greek side.

(WikiT)...

Asiandouble Eyelid in CY (Cyprus) - How Is It Done?

Normally, in the Asian eyelid, the aim is to realign structurally the eyelid tissues for creating a natural crease when the upper eyelid is opened. On the other hand, in the non-Asian eyelid, the plastic surgery is done for subtracting the changes that result from aging. Though a few persons, particularly women, prefer a prominent crease of medium height and parallel contour, only a low and tapered crease would be natural and that should be chosen. A high crease would never look good on a male.

This delicate cosmetic procedure of correcting the Asian double eyelid involves very little removal of skin and fat. The plastic surgery focuses on the realignment of the internal eyelid structure. The plastic surgeon should take a customized approach for each patient and adopt the most suitable surgical technique. The surgery is done with a local anesthesia so that the patient could open and close the eyes during the surgery. This would help the surgeon to monitor constantly the changes to the position and shape of the eyelids.

[asiandouble eyelid CY top]

Asiandouble Eyelid in CY (Cyprus) - After the Surgery:

Small incisions are made and strips of skin are excised to attain the right height for the new crease. In certain cases, no skin would be removed. However, the orbital muscle and orbital septum strips are removed in minute quantities to change the height of the crease. The final height of the crease would depend on the level of tissue removal and the rearrangement of the internal tissue. Creases of parallel, tapered, lateral flare, and sometimes semi lunar shapes could be created by this special eye surgery. Multiple creases could also be corrected through this cosmetic procedure.

[asiandouble eyelid CY top]

CY asiandouble eyelid - News update:

Context The erythropoiesis-stimulating agents (ESAs) erythropoietin and darbepoetin are licensed to treat chemotherapy-associated anemia in patients with nonmyeloid malignancies. Although systematic overviews of trials have identified venous thromboembolism (VTE) risks, none have identified mortality risks with ESAs.

Objective To evaluate VTE and mortality rates associated with ESA administration for the treatment of anemia among patients with cancer.

Data Sources A published overview from the Cochrane Collaboration (search dates: January 1, 1985-April 1, 2005) and MEDLINE and EMBASE databases (key words: clinical trial, erythropoietin, darbepoetin, and oncology), the public Web site of the US Food and Drug Administration and ESA manufacturers, and safety advisories (search dates: April 1, 2005-January 17, 2008).

Study Selection Phase 3 trials comparing ESAs with placebo or standard of care for the treatment of anemia among patients with cancer.

Data Extraction Mortality rates, VTE rates, and 95% confidence intervals (CIs) were extracted by 3 reviewers from 51 clinical trials with 13 611 patients that included survival information and 38 clinical trials with 8172 patients that included information on VTE.

Data Synthesis Patients with cancer who received ESAs had increased VTE risks (334 VTE events among 4610 patients treated with ESA vs 173 VTE events among 3562 control patients; 7.5% vs 4.9%; relative risk, 1.57; 95% CI, 1.31-1.87) and increased mortality risks (hazard ratio, 1.10; 95% CI, 1.01-1.20).

Conclusions Erythropoiesis-stimulating agent administration to patients with cancer is associated with increased risks of VTE and mortality. Our findings, in conjunction with basic science studies on erythropoietin and erythropoietin receptors in solid cancers, raise concern about the safety of ESA administration to patients with cancer.

More...

[asiandouble eyelid CY top]

cyprus asiandouble eyelid